Get the latest tech news
Israeli scientist uncovers breakthrough Hepatitis B treatment
A research team led by Dr. Yael David of Memorial Sloan Kettering Cancer Center discovers that a chemotherapy drug, Curaxin-137, can effectively disable a key viral protein, nearly eliminating the hepatitis B virus in lab tests
A groundbreaking study led by Dr. Yael David of Memorial Sloan Kettering Cancer Center (MSK) cracked a decades-old mystery and discovered a promising path toward the first-ever drug treatment for Hepatitis B —one of the deadliest diseases in the world. They are now in advanced talks with major pharmaceutical companies to develop this treatment, and their findings have caught the attention of Dr. Charles Rice, a Nobel Prize-winning scientist known for his work on hepatitis C. To understand how the virus infects cells, the researchers studied its genetic makeup and found that it relies on a mysterious protein called “X protein.” Until now, scientists knew very little about this protein—Dr.
Or read this on r/technology